Atherogenic oxidized low-density lipoprotein/β2- glycoprotein I (oxLDL/β2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome

Eiji Matsuura, K. Kobayashi, B. L. Hurley, L. R. Lopez

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)


Oxidized low-density lipoprotein (oxLDL) interacts in vitro with β2-glycoprotein I (β2GPI) via LDL-derived specific ligands forming oxLDL/β2GPI complexes. Circulating oxLDL/β2GPI complexes have been demonstrated in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Autoimmune vascular inflammation and oxidative stress contribute to oxLDL/β2GPI complex formation. Immunohistochemical staining of atherosclerotic lesions suggest that these complexes are formed in the arterial wall and released into circulation. The demonstration of antibodies to oxLDL/β2GPI complexes indicates that these complexes are immunogenic, and the coexistence of complexes and antibodies suggest an active pro-thrombotic/pro-atherogenic role in the development of autoimmune vascular complications. Circulating oxLDL/β2GPI complexes can be measured by ELISA using a monoclonal antibody specific to complexed human β2GPI to capture β2GPI bound to oxLDL. An enzyme-conjugated monoclonal antibody to human Apo B 100 allows the specific detection of oxLDL/β2GPI complexes. OxLDL/β2GPI complexes were common in SLE and APS patients suggesting an underlying process of inflammation and oxidation. Using oxLDL/β2GPI complexes as capture antigen, antibodies to oxLDL/β2GPI can be measured by ELISA. Serum levels of IgG anti-oxLDL/β2GPI antibodies were significantly higher in SLE patients with APS compared to SLE controls without APS. Further, high titers of these IgG antibodies were observed in APS patients with a history of arterial thrombosis. The presence of circulating oxLDL/β2GPI complexes and IgG antibodies to these complexes indicates significant vascular injury and oxidative stress as well as an active role in autoimmune-mediated atherothrombosis.

Original languageEnglish
Pages (from-to)478-483
Number of pages6
Issue number7
Publication statusPublished - 2006


  • Antiphospholipid antibodies
  • Autoimmunity
  • Oxidized-LDL antibodies

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Atherogenic oxidized low-density lipoprotein/β<sub>2</sub>- glycoprotein I (oxLDL/β<sub>2</sub>GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome'. Together they form a unique fingerprint.

Cite this